HAYWARD, Calif.--(BUSINESS WIRE)--May 23, 2008--IMPAX
Laboratories, Inc. (OTC: IPXL) today announced that Arthur A. Koch,
Jr., its senior vice president and chief financial officer, will
present at the UBS Global Specialty and Generic Pharmaceuticals
Conference on Thursday, May 29th, at 10:00 a.m. London GMT (5:00 a.m.
ET). The conference will be held at The Waldorf Hilton Hotel, Aldwych,
London from May 28 to 29, 2008.
Individuals may listen to the live or an archived presentation
made at the conference, which will be posted in the investor relations
section of the Company's web site at www.impaxlabs.com. To listen to
the live presentation, please go to the web site 15 minutes prior to
its start to register, download, and install the necessary audio
software. This presentation will be archived on the Company's web site
for 90 days. The Company's regular Corporate presentation will be
updated and posted on the Company's web site on that date as well.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
IMPAX markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the IMPAX
Pharmaceuticals division. Additionally, where strategically
appropriate, IMPAX has developed marketing partnerships to fully
leverage its technology platform. IMPAX Laboratories is headquartered
in Hayward, California, and has a full range of capabilities in its
Hayward and Philadelphia facilities. For more information, please
visit the Company's Web site at: www.impaxlabs.com.
CONTACT: IMPAX Laboratories, Inc.
Larry Hsu, Ph.D., President & CEO
510-476-2000, Ext. 1111
Arthur A. Koch, Jr., Sr. VP & CFO
215-933-0351
Mark Donohue, Sr. Director IR
215-933-3526
www.impaxlabs.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
[email protected]
Bruce Voss, 310-691-7100
[email protected]
www.lhai.com
SOURCE: IMPAX Laboratories, Inc.